Joanne Spadoro Net Worth & Insider Trades

Joanne Spadoro - Chief Operations Officer, T2 Biosystems, Inc

As of June 8, 2017

What is Joanne Spadoro's Net Worth?

The current estimated net worth of T2 Biosystems, Inc's Chief Operations Officer, Joanne Spadoro, is estimated to be about $1.05K . Joanne Spadoro owns about 5,589 units of T2 Biosystems, Inc common stock. In the last year at T2 Biosystems, Inc, Joanne Spadoro has sold an estimated value of $0 worth.

What is Joanne Spadoro's Past Insider Trading?

Joanne Spadoro's largest purchase order was 5,000 units , worth over $17.5K on June 8, 2017. In total, Joanne Spadoro has made about 3 transactions over a year of their time at T2 Biosystems, Inc. Joanne Spadoro usually trades in September, February and June, with the busiest year in 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Joanne Spadoro's' Mailing Address?

  • Mailing address is 101 Hartwell Ave. Lexington MA 02421 MA

T2 Biosystems, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John Sperzel, 2020 $490,705 - - $2,571,384 $393,750 $3,000 $3,458,839
John McDonough, 2020 $72,906 - $74,999 - - $1,022,182 $1,170,087
John McDonough, 2019 $550,000 - $372,000 $478,728 $233,750 $3,000 $1,637,478
Alec Barclay, 2020 $340,000 - $25,675 $38,621 $234,600 $952 $639,848
Alec Barclay, 2019 $337,500 $35,000 $111,600 $348,834 $102,000 $2,900 $937,834
Anthony Pare, 2020 $325,000 - $20,738 $159,763 $185,250 $3,000 $693,751
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm

What are T2 Biosystems, Inc's Past Insider Trades?

T2 Biosystems, Inc's most recent insider trade came on April 11, 2022 by John Sperzel III who bought 30,000 units worth $15K . In the last 8 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.08M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer,  David Elsbree, Director,  and Terrence Michael Gibbs, General Counsel .

T2 Biosystems, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1